Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Women with PCOS have altered brain structure and reduced cognitive performance.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

PCOS has no cure, but treatments can manage symptoms and improve health.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Fat-derived stem cells and their secretions show promise for treating skin aging and hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.